HIV-infected cells persist for decades in patients administered with antiretroviral therapy (ART). Meanwhile, an alarming surge drug-resistant HIV viruses has been occurring. Addressing these issues, we propose the application of photoimmunotherapy (PIT) against not only Env-expressing but also HIV. Previously, showed that a human anti-gp41 antibody (7B2) conjugated to cationic or anionic photo...